Managing 7-Hydroxymitragynine Use Disorder with Buprenorphine-Naloxone
Hawai‘i Journal of Health & Social Welfare · 2026
DOI: 10.62547/gahw6645 ↗Kurz gefasst
Fallbericht in der Zeitschrift Hawai‘i Journal of Health & Social Welfare, 2026. Verfasst von Miki Kiyokawa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Department of Medicine University of Hawai'i at Mānoa, John A Burns School of Medicine. Hauptthemen laut MEDLINE: Buprenorphine, Naloxone Drug Combination, Secologanin Tryptamine Alkaloids, Substance-Related Disorders. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry and Department of Medicine University of Hawai'i at Mānoa, John A Burns School of Medicine.
- University of Hawai'i at Mānoa, John A Burns School of Medicine.
- Department of Psychiatry University of Hawai'i at Mānoa, John A Burns School of Medicine.
ORCID-Profile: Miki Kiyokawa
Zitieren
APA
Kiyokawa, M., Chun, A., & Hsia, C. (2026). Managing 7-Hydroxymitragynine Use Disorder with Buprenorphine-Naloxone. Hawai‘i Journal of Health & Social Welfare. https://doi.org/10.62547/gahw6645
Vancouver
Kiyokawa M, Chun A, Hsia C. Managing 7-Hydroxymitragynine Use Disorder with Buprenorphine-Naloxone. Hawai‘i Journal of Health & Social Welfare. 2026. doi:10.62547/gahw6645
BibTeX
@article{Kiyokawa2026,
author = {Kiyokawa, Miki and Chun, Alex and Hsia, Charlene},
title = {Managing 7-Hydroxymitragynine Use Disorder with Buprenorphine-Naloxone},
journal = {Hawai‘i Journal of Health & Social Welfare},
year = {2026},
doi = {10.62547/gahw6645}
}
EUVIMED